Literature DB >> 15170398

Amniotic fluid embolism with haemostasis complications: primary fibrinogenolysis or disseminated intravascular coagulation?

C Biron-Andréani1, E Morau, J-F Schved, B Hédon, H Dechaud.   

Abstract

Amniotic fluid embolism (AFE) is characterized by the passage of amniotic fluid (AF) into the maternal circulation during or just after childbirth. AFE is a rare disorder occurring in 1/8,000 to 1/80,000 deliveries but with a maternal morbidity ranging from 26% in a recent report to 86% in earlier ones. In patients who survive, AFE may affect coagulation resulting in severe bleeding. While disseminated intravascular coagulation (DIC) is usually seen in such cases, we reported a case of AFE in which the hemostatic abnormalities were compatible with primary fibrinogenolysis rather than with DIC. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 15170398     DOI: 10.1159/000077826

Source DB:  PubMed          Journal:  Pathophysiol Haemost Thromb        ISSN: 1424-8832


  7 in total

1.  Emergencies associated with pregnancy and delivery: peripartum hemorrhage.

Authors:  Franz Kainer; Uwe Hasbargen
Journal:  Dtsch Arztebl Int       Date:  2008-09-12       Impact factor: 5.594

Review 2.  [Hemorrhaging during pregnancy].

Authors:  S Hofer; R Schreckenberger; B Heindl; K Görlinger; H Lier; H Maul; E Martin; M A Weigand
Journal:  Anaesthesist       Date:  2007-10       Impact factor: 1.041

Review 3.  Amniotic fluid embolism: an interdisciplinary challenge: epidemiology, diagnosis and treatment.

Authors:  Werner H Rath; Stefan Hoferr; Inga Sinicina
Journal:  Dtsch Arztebl Int       Date:  2014-02-21       Impact factor: 5.594

4.  Coagulopathy following venous air embolism: a disastrous consequence -a case report-.

Authors:  Srilata Moningi; Dilip Kulkarni; Suchanda Bhattacharjee
Journal:  Korean J Anesthesiol       Date:  2013-10-24

5.  TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial.

Authors:  Anne-Sophie Ducloy-Bouthors; Emmanuelle Jeanpierre; Imen Saidi; Anne-Sophie Baptiste; Elodie Simon; Damien Lannoy; Alain Duhamel; Delphine Allorge; Sophie Susen; Benjamin Hennart
Journal:  Trials       Date:  2018-03-01       Impact factor: 2.279

6.  Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial.

Authors:  Anne-Sophie Bouthors; Benjamin Hennart; Emmanuelle Jeanpierre; Anne-Sophie Baptiste; Imen Saidi; Elodie Simon; Damien Lannoy; Alain Duhamel; Delphine Allorge; Sophie Susen
Journal:  Trials       Date:  2018-03-01       Impact factor: 2.279

7.  Consumptive Coagulopathy Involving Amniotic Fluid Embolism: The Importance of Earlier Assessments for Interventions in Critical Care.

Authors:  Tomoaki Oda; Naoaki Tamura; Rui Ide; Toshiya Itoh; Yoshimasa Horikoshi; Masako Matsumoto; Megumi Narumi; Yukiko Kohmura-Kobayashi; Naomi Furuta-Isomura; Chizuko Yaguchi; Toshiyuki Uchida; Kazunao Suzuki; Hiroaki Itoh; Naohiro Kanayama
Journal:  Crit Care Med       Date:  2020-12       Impact factor: 9.296

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.